FI951901L - Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus - Google Patents

Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus Download PDF

Info

Publication number: FI951901L
Authority: FI; Finland
Prior art keywords: release; orally administered; administered formulation; stable extended; extended
Prior art date: 1992-10-23

Application number

FI951901A

Other languages

English (en)

Swedish (sv)

Other versions

FI112916B (fi

FI951901A0 (fi

Inventor

Henry K Kwan

Stephen M Liebowitz

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-23

Filing date

1995-04-21

Publication date

1995-04-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25510010&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI951901(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-04-21 Application filed by Schering Corp filed Critical Schering Corp

1995-04-21 Publication of FI951901L publication Critical patent/FI951901L/fi

1995-04-21 Publication of FI951901A0 publication Critical patent/FI951901A0/fi

2004-02-13 Application granted granted Critical

2004-02-13 Publication of FI112916B publication Critical patent/FI112916B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

FI951901A 1992-10-23 1995-04-21 Menetelmä kalvopäällystetyn pidennetysti vapauttavan, oraalisesti annosteltavan koostumuksen valmistamiseksi FI112916B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US07/965,470 US5314697A (en)	1992-10-23	1992-10-23	Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US96547092		1992-10-23
PCT/US1993/009873 WO1994009761A1 (en)	1992-10-23	1993-10-21	Stable extended release oral dosage composition
US9309873		1993-10-21

Publications (3)

Publication Number	Publication Date
FI951901L true FI951901L (fi)	1995-04-21
FI951901A0 FI951901A0 (fi)	1995-04-21
FI112916B FI112916B (fi)	2004-02-13

Family

ID=25510010

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI951901A FI112916B (fi)	1992-10-23	1995-04-21	Menetelmä kalvopäällystetyn pidennetysti vapauttavan, oraalisesti annosteltavan koostumuksen valmistamiseksi

Country Status (28)

Country	Link
US (1)	US5314697A (fi)
EP (1)	EP0665744B1 (fi)
JP (1)	JP3580815B2 (fi)
KR (1)	KR100283709B1 (fi)
CN (1)	CN1038474C (fi)
AT (1)	ATE161420T1 (fi)
AU (1)	AU676229B2 (fi)
CA (1)	CA2147606C (fi)
CZ (1)	CZ287687B6 (fi)
DE (1)	DE69316023T2 (fi)
DK (1)	DK0665744T3 (fi)
EE (1)	EE03106B1 (fi)
ES (1)	ES2110633T3 (fi)
FI (1)	FI112916B (fi)
GR (1)	GR3026198T3 (fi)
HK (1)	HK1004327A1 (fi)
HU (1)	HU220629B1 (fi)
IL (1)	IL107354A (fi)
MY (1)	MY109090A (fi)
NO (1)	NO308771B1 (fi)
NZ (1)	NZ257447A (fi)
PH (1)	PH29940A (fi)
PL (1)	PL172862B1 (fi)
SG (1)	SG42947A1 (fi)
SK (1)	SK281090B6 (fi)
TW (1)	TW251239B (fi)
WO (1)	WO1994009761A1 (fi)
ZA (1)	ZA937830B (fi)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996010996A1 (en) *	1993-07-21	1996-04-18	The University Of Kentucky Research Foundation	A multicompartment hard capsule with control release properties
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en)	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US7211582B1 (en)	1994-12-30	2007-05-01	Sepracor Inc.	Methods for treating urticaria using descarboethoxyloratadine
US7214683B1 (en)	1994-12-30	2007-05-08	Sepracor Inc.	Compositions of descarboethoxyloratadine
KR100405116B1 (ko)	1995-02-28	2004-02-05	아벤티스 파마슈티칼스 인크.	피페리디노알칸올화합물에대한약제학적조성물
US5807579A (en) *	1995-11-16	1998-09-15	F.H. Faulding & Co. Limited	Pseudoephedrine combination pharmaceutical compositions
EP0811374A1 (en)	1996-05-29	1997-12-10	Pfizer Inc.	Combination dosage form comprising cetirizine and pseudoephedrine
HUP9904075A3 (en) *	1996-10-31	2002-02-28	Schering Corp	Composition, for the treatment of asthma,containing loratadine and a decongestant
PE71699A1 (es) *	1997-02-07	1999-08-03	Sepracor Inc	Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
BE1011045A3 (fr)	1997-03-14	1999-04-06	Ucb Sa	Compositions pharmaceutiques pour la liberation controlee de substances actives.
PT998272E (pt) *	1997-08-26	2003-09-30	Aventis Pharma Inc	Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
PA8481801A1 (es) *	1998-09-10	2000-09-29	Schering Corp	Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6051585A (en) *	1998-12-07	2000-04-18	Weinstein; Robert E.	Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en)	1998-12-07	2003-02-18	J-Med Pharmaceuticals, Inc.	Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) *	1999-02-23	2005-08-01	주식회사유한양행	로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
CN1161112C (zh) *	1999-02-23	2004-08-11	株式会社柳韩洋行	含氯雷他定和伪麻黄碱的药物胶囊组合物
US6555139B2 (en)	1999-06-28	2003-04-29	Wockhardt Europe Limited	Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) *	1999-07-07	2000-08-08	Schering Corporation	8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6267986B1 (en) *	1999-09-24	2001-07-31	Ranbaxy Laboratories Limited	Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) *	1999-10-22	2000-09-05	Schering Corporation	Treating sleep disorders using desloratadine
SK287684B6 (sk) *	1999-12-20	2011-06-06	Schering Corporation	Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SK287105B6 (sk) *	1999-12-20	2009-12-07	Schering Corporation	Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US6613357B2 (en) *	2000-01-13	2003-09-02	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist
US7147870B2 (en) *	2000-01-13	2006-12-12	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
AU4248400A (en) *	2000-04-14	2001-10-30	J Med Pharmaceuticals Inc	Single-dose antihistamine/decongestant formulations for treating rhinitis
US20020094345A1 (en) *	2000-10-06	2002-07-18	Sara Abelaira	Pharmaceutical compositions containing epinastine and pseudoephedrine
WO2002036077A2 (en) *	2000-11-06	2002-05-10	Andrx Pharmaceuticals, Inc.	Once a day antihistamine and decongestant formulation
EP1401444A1 (en) *	2001-06-20	2004-03-31	Schering Corporation	Antihistamines for the treatment of nasal congestion and nasal obstruction
WO2004019917A1 (es) *	2002-08-29	2004-03-11	Osmotica Corp.	Dispositivo de liberacion de droga que contiene oseltamivir y un antagonista h1
US6720002B2 (en)	2001-07-20	2004-04-13	R.P. Scherer Technologies, Inc.	Antihistamine formulations for soft capsule dosage forms
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) *	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
US20040051686A1 (en) *	2002-09-17	2004-03-18	Yuan-Sung Weng	Carry-on device having functions of both digital photographing and timing
US8092831B2 (en) *	2002-11-08	2012-01-10	Andrx Pharmaceuticals, Llc	Antihistamine and decongestant system
US20050013863A1 (en) *	2003-07-18	2005-01-20	Depomed, Inc., A Corporation Of The State Of California	Dual drug dosage forms with improved separation of drugs
KR20060092255A (ko)	2003-09-26	2006-08-22	알자 코포레이션	고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US20050095288A1 (en) *	2003-11-03	2005-05-05	Andrx Labs, Llc	Decongestant and expectorant tablets
JP4999329B2 (ja) *	2003-12-01	2012-08-15	武田薬品工業株式会社	固形製剤の印刷前処理方法
US20050266032A1 (en) *	2003-12-17	2005-12-01	Sovereign Pharmaceuticals, Ltd.	Dosage form containing multiple drugs
SE0401031D0 (sv)	2004-04-22	2004-04-22	Duocort Ab	A new glucocorticoid replacement therapy
US20060024368A1 (en) *	2004-07-30	2006-02-02	Reza Fassihi	Compressed composite delivery system for release-rate modulation of bioactives
MX2007009088A (es) *	2005-01-27	2007-09-13	Alembic Ltd	Formulacion de liberacion extendida de levetiracetam.
US20070036859A1 (en) *	2005-08-11	2007-02-15	Perry Ronald L	Sustained release antihistamine and decongestant composition
CA2653955C (en) *	2006-06-01	2015-10-27	Schering Corporation	Pharmaceutical compositions for sustained release of phenylephrine
CN101015519B (zh) *	2007-02-27	2012-03-21	重庆医药工业研究院有限责任公司	一种氯雷他定口服复方药物组合物
US20080207593A1 (en) *	2007-02-28	2008-08-28	Collegium Pharmaceutical, Inc.	Antihistamine Combination
EP2299983A4 (en) *	2008-07-24	2012-10-10	Handa Pharmaceuticals Llc	ATYPICAL ANTIPSYCHOTIC FORMULATION STABILIZED
DK3045043T3 (da)	2009-02-26	2020-08-03	Relmada Therapeutics Inc	Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
CA2690490C (en)	2010-01-19	2012-06-26	Accucaps Industries Limited	Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CN102160859B (zh) *	2011-02-23	2012-11-07	海南斯达制药有限公司	一种氯雷伪麻复方缓释药物
JP5752578B2 (ja) *	2011-12-09	2015-07-22	ジェイ−メドファーマシューティカルズ，インコーポレーティッド	鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
CN104983708A (zh) *	2015-06-24	2015-10-21	万特制药(海南)有限公司	一种地氯雷他定硫酸伪麻黄碱缓释片及其制备方法
CN108576895B (zh) *	2018-03-06	2021-04-30	特素生物科技（天津）有限公司	缓释营养主食及其制备方法
PE20231844A1 (es)	2020-07-30	2023-11-21	Faes Farma Sa	Sistema de liberacion de farmacos descongestivos y bilastina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4282233B1 (en) *	1980-06-19	2000-09-05	Schering Corp	Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4601894A (en) *	1985-03-29	1986-07-22	Schering Corporation	Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
IE60311B1 (en) *	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
CN1053570C (zh) *	1987-10-07	2000-06-21	默尔多药物公司	哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

1992
- 1992-10-23 US US07/965,470 patent/US5314697A/en not_active Expired - Lifetime
1993
- 1993-10-21 JP JP51111094A patent/JP3580815B2/ja not_active Expired - Lifetime
- 1993-10-21 SG SG1996001282A patent/SG42947A1/en unknown
- 1993-10-21 IL IL107354A patent/IL107354A/en not_active IP Right Cessation
- 1993-10-21 MY MYPI93002189A patent/MY109090A/en unknown
- 1993-10-21 EP EP93924327A patent/EP0665744B1/en not_active Expired - Lifetime
- 1993-10-21 KR KR1019950701529A patent/KR100283709B1/ko not_active Expired - Lifetime
- 1993-10-21 AU AU54050/94A patent/AU676229B2/en not_active Expired
- 1993-10-21 PL PL93308491A patent/PL172862B1/pl unknown
- 1993-10-21 CA CA002147606A patent/CA2147606C/en not_active Expired - Lifetime
- 1993-10-21 DE DE69316023T patent/DE69316023T2/de not_active Expired - Lifetime
- 1993-10-21 ZA ZA937830A patent/ZA937830B/xx unknown
- 1993-10-21 NZ NZ257447A patent/NZ257447A/en not_active IP Right Cessation
- 1993-10-21 ES ES93924327T patent/ES2110633T3/es not_active Expired - Lifetime
- 1993-10-21 AT AT93924327T patent/ATE161420T1/de active
- 1993-10-21 HU HU9501143A patent/HU220629B1/hu unknown
- 1993-10-21 SK SK522-95A patent/SK281090B6/sk not_active IP Right Cessation
- 1993-10-21 PH PH47120A patent/PH29940A/en unknown
- 1993-10-21 HK HK98103388A patent/HK1004327A1/en not_active IP Right Cessation
- 1993-10-21 CZ CZ19951014A patent/CZ287687B6/cs not_active IP Right Cessation
- 1993-10-21 DK DK93924327T patent/DK0665744T3/da active
- 1993-10-21 WO PCT/US1993/009873 patent/WO1994009761A1/en not_active Ceased
- 1993-10-22 CN CN93118769A patent/CN1038474C/zh not_active Expired - Lifetime
- 1993-10-22 TW TW082108823A patent/TW251239B/zh not_active IP Right Cessation
1994
- 1994-11-21 EE EE9400250A patent/EE03106B1/xx unknown
1995
- 1995-04-21 NO NO19951527A patent/NO308771B1/no not_active IP Right Cessation
- 1995-04-21 FI FI951901A patent/FI112916B/fi not_active IP Right Cessation
1998
- 1998-02-23 GR GR980400376T patent/GR3026198T3/el unknown

Also Published As

Publication number	Publication date
MY109090A (en)	1996-11-30
PH29940A (en)	1996-09-16
CA2147606C (en)	2000-10-10
ATE161420T1 (de)	1998-01-15
DE69316023D1 (de)	1998-02-05
SG42947A1 (en)	1997-10-17
HU220629B1 (hu)	2002-03-28
SK52295A3 (en)	1997-05-07
DE69316023T2 (de)	1998-04-23
ZA937830B (en)	1994-04-21
HUT71682A (en)	1996-01-29
AU676229B2 (en)	1997-03-06
AU5405094A (en)	1994-05-24
DK0665744T3 (da)	1998-09-07
FI112916B (fi)	2004-02-13
WO1994009761A1 (en)	1994-05-11
KR950703937A (ko)	1995-11-17
EP0665744B1 (en)	1997-12-29
NO951527L (no)	1995-06-20
US5314697A (en)	1994-05-24
NO308771B1 (no)	2000-10-30
EP0665744A1 (en)	1995-08-09
NO951527D0 (no)	1995-04-21
CA2147606A1 (en)	1994-05-11
PL172862B1 (pl)	1997-12-31
CZ287687B6 (en)	2001-01-17
JP3580815B2 (ja)	2004-10-27
HK1004327A1 (en)	1998-11-20
JPH08502516A (ja)	1996-03-19
NZ257447A (en)	1996-09-25
IL107354A (en)	1998-02-08
TW251239B (fi)	1995-07-11
CN1089471A (zh)	1994-07-20
GR3026198T3 (en)	1998-05-29
EE03106B1 (et)	1998-08-17
PL308491A1 (en)	1995-08-07
SK281090B6 (sk)	2000-11-07
ES2110633T3 (es)	1998-02-16
IL107354A0 (en)	1994-01-25
CZ101495A3 (en)	1996-02-14
KR100283709B1 (ko)	2001-03-02
CN1038474C (zh)	1998-05-27
FI951901A0 (fi)	1995-04-21
HU9501143D0 (en)	1995-06-28

Publication	Publication Date	Title
FI951901L (fi)	1995-04-21	Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
DK0585252T3 (da)	2001-11-12	Farmaceutiske formuleringer
DK0515312T3 (da)	1996-11-18	Farmaceutisk præparat
ITBO910024A1 (it)	1992-07-30	Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
DE69224656D1 (de)	1998-04-09	Arzneimittel
NO922506D0 (no)	1992-06-25	Farmasoeytiske preparat
FI921060A0 (fi)	1992-03-11	Farmaceutiska aerosolformuleringar.
FI922252A0 (fi)	1992-05-18	Farmaceutisk sammansaettning.
ATE98480T1 (de)	1994-01-15	Arzneimittelformulierungen.
FI912952L (fi)	1991-12-29	Kontrollerbart frigoerande farmaceutiskt preparat.
MX9102473A (es)	1992-06-01	Agentes farmaceuticos.
FI950947L (fi)	1995-09-03	Oraalisesti annettavat farmaseuttiset formulaatiot
FI910851A0 (fi)	1991-02-22	3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen.
DK0390369T3 (da)	1994-04-11	Oralt indgivelige ibuprofenpræparater
FI923581A0 (fi)	1992-08-11	Farmaceutisk kombinationsformation.
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
DE68903192D1 (de)	1992-11-19	Orale praeparate.
FI925633L (fi)	1993-06-13	Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
FI925778A0 (fi)	1992-12-18	Farmaceutiskt aktiva bensokinazolinfoereningar
DZ1559A1 (fr)	2002-02-17	Compositions pharmaceutiques.
FR2698268B1 (fr)	1995-01-20	Composition photoprotectrice administrée par voie orale.
NO950134D0 (no)	1995-01-13	Formuleringer for oralt administrerte farmasöytiske midler
DZ1926A1 (fr)	2002-02-17	Formulations pharmaceutiques.
FI923371A0 (fi)	1992-07-24	En farmaceutisk formulation.
FI921785A7 (fi)	1992-10-24	Farmaceutisk foerening

Legal Events

Date	Code	Title	Description
2012-08-27	PC	Transfer of assignment of patent	Owner name: MERCK SHARP & DOHME CORP.
2013-11-29	MA	Patent expired